| Issue Date | Title | Author(s) |
| 2013-07-01 | Cost-effectiveness of an advance notification letter to increase colorectal cancer screening | Cronin, P; Goodall, S; Lockett, T; O'Keefe, CM; Norman, R; Church, J |
| 2018-06-01 | Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model | Saing, S; Haywood, P; Duncan, JK; Ma, N; Cameron, AL; Goodall, S |
| 2017-10-30 | SCORE: Shared care of Colorectal cancer survivors: Protocol for a randomised controlled trial | Jefford, M; Emery, J; Grunfeld, E; Martin, A; Rodger, P; Murray, AM; De Abreu Lourenco, R; Heriot, A; Phipps-Nelson, J; Guccione, L; King, D; Lisy, K; Tebbutt, N; Burgess, A; Faragher, I; Woods, R; Schofield, P |
| 2014-02-01 | Responsiveness was similar between direct and mapped SF-6D in colorectal cancer patients who declined | Wong, CKH; Mulhern, B; Wan, YF; Lam, CLK |
| 2012-11-22 | Chemotherapy administration: Modelling the costs of alternative protocols | Haywood, P; De Raad, J; Van Gool, K; Haas, M; Gallego, G; Pearson, SA; Faedo, M; Ward, R |
| 2013-08-01 | Measurement invariance of the Functional Assessment of Cancer Therapy - Colorectal quality-of-life instrument among modes of administration | Wong, CKH; Lam, CLK; Mulhern, B; Law, WL; Poon, JTC; Kwong, DLW; Tsang, J |
| 2017-10-01 | Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study | Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R |
| 2018-07-25 | The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: Study protocol for a randomised controlled trial | Walker, JG; Macrae, F; Winship, I; Oberoi, J; Saya, S; Milton, S; Bickerstaffe, A; Dowty, JG; De Abreu Lourenço, R; Clark, M; Galloway, L; Fishman, G; Walter, FM; Flander, L; Chondros, P; Ait Ouakrim, D; Pirotta, M; Trevena, L; Jenkins, MA; Emery, JD |
